Robert Mionis, CEO, has demonstrated a consistent pattern of selling activity across two companies—Celestica Inc. (CLS) and Textron Inc. (TXT)—with no recorded purchases in his 27 reported transactions. His total sales exceed $214 million, all concentrated in CLS, with no buys offsetting the disposals. The most recent trades, spanning February 2026, include multiple sales of CLS shares, such as a $1.42 million transaction on February 4 and a substantial $86.3 million sale on February 2. Earlier activity in February 2025 also featured significant disposals, including a $53.97 million sale on February 3 and a $33.72 million transaction on February 1. The only TXT-related filing, dated March 2025, was an award transaction with no associated market activity. Mionis’s trading history reveals an unambiguous sell-side bias, with CLS as the primary focus. The absence of any buys, combined with the scale and frequency of sales—particularly the eight recent disposals—suggests a sustained reduction in his holdings. The transactions appear methodical, with no erratic timing or valuation outliers, reflecting a deliberate approach to divestment.
AI-assisted summary